ALEXION PHARMACEUTICALS, INC. ALXN Income Statement

Alexion pharmaceuticals, inc. (ALXN)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Total revenues
1,444,800	1,384,300	1,263,100	1,203,300	1,140,400	1,128,800	1,026,500	1,045,000	930,900	909,700	859,100	912,700	869,600	831,100	799,000	753,000	701,000	700,820	666,637	636,210	600,333	-	555,146	512,495	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of sales:
Cost of sales (exclusive of amortization of purchased intangible assets)
111,700	114,300	95,200	99,200	85,800	96,800	90,600	95,300	91,600	144,600	157,000	83,600	69,000	68,300	71,000	60,000	59,000	57,637	54,057	52,007	69,399	49,577	51,858	39,626	32,939	51,552	42,177	39,377	35,269	33,147	33,186	31,613	28,268	28,798	23,369	21,745	19,228	20,222	16,495	13,721	13,999	11,895	10,313
Gain on intellectual property settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Change in contingent liability from intellectual property settlements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9,181	-	-	-	53,377	-	-	-	-	-	-	-	-	-	-	-	-
Total cost of sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	51,358	-	-	-	-20,191	-	-	-	23,369	-	-	-	-	-	-	-	-
Research and development
200,900	269,600	232,900	187,600	195,900	205,600	174,800	173,400	176,600	265,000	195,700	198,200	219,500	206,200	195,000	180,000	176,000	191,063	165,664	131,693	221,080	129,328	100,661	92,554	191,457	85,785	88,209	68,563	74,536	63,409	54,280	59,635	45,408	34,398	36,567	35,646	30,810	27,177	25,153	23,690	22,374	21,323	18,288
Selling, general and administrative
319,900	381,000	299,300	299,300	281,500	318,700	258,700	277,300	257,100	296,400	270,600	265,600	261,800	258,000	230,000	232,000	233,000	241,581	212,520	221,383	187,116	183,567	157,665	159,477	129,291	134,819	122,886	123,189	108,826	112,624	89,957	94,855	87,242	86,566	77,572	78,180	65,858	62,825	57,208	56,098	50,635	41,523	42,705
Research and Development Asset Acquired Other than Through Business Combination, Written-off
-	-	0	-4,100	-	-	0	803,700	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of purchased intangible assets
73,700	73,900	75,600	80,100	80,000	80,000	80,000	80,100	80,000	80,000	80,000	80,100	80,000	80,200	82,000	80,000	80,000	79,992	36,608	0	0	-	0	-	-	105	104	104	104	105	104	104	104	105	104	104	69	-	-	-	-	-	-
Change in fair value of contingent consideration
5,800	4,400	29,800	6,100	-28,700	5,600	53,500	4,700	52,700	9,200	3,700	24,600	3,500	4,700	41,000	5,000	-15,000	18,493	29,684	4,044	11,979	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition-related costs
38,100	-	-	-	0	-	-	-	-	-	-	-	-	300	0	1,000	1,000	3,348	6,075	29,777	0	-10,254	8,303	1,989	-38	-5,951	2,573	1,167	3,234	3,365	967	4,807	13,673	2,322	236	1,000	9,928	-	-	-	-	-	-
Restructuring expenses
-800	100	300	2,500	9,100	-900	10,300	10,600	5,500	5,900	72,000	2,900	23,800	1,000	1,000	0	1,000	11,363	7,461	16,224	7,052	15,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
749,300	-	-	-	623,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangible assets
-	-	-	-	-	-	-	-	-	-	0	31,000	-	-	0	0	-	-	-	-	-	8,536	0	0	3,464	33,521	0	0	0	-	26,300	-	-	-	0	-	-	-	-	-	-	-	-
Total operating expenses
-	-	637,900	571,500	-	988,300	577,300	1,349,800	571,900	656,500	622,000	602,400	588,600	635,400	549,000	498,000	476,000	545,840	458,012	403,121	427,227	346,177	266,629	254,020	324,174	252,285	213,772	193,023	186,700	179,503	171,608	159,401	146,427	123,391	114,479	114,930	106,665	90,724	82,361	79,788	73,009	62,846	60,993
Operating income
695,500	541,000	530,000	532,600	516,800	43,700	358,600	-400,100	267,400	108,600	80,100	226,700	212,000	127,400	179,000	195,000	166,000	97,343	154,568	181,082	103,707	203,989	236,659	218,849	209,503	138,072	135,275	137,691	116,972	107,876	142,719	83,705	70,038	75,370	66,199	49,024	40,233	45,030	42,713	32,325	30,570	27,887	20,950
Other income and expense:
Investment (expense) income
-5,200	49,700	23,000	-14,900	42,500	-54,100	5,900	7,700	105,800	5,600	4,500	4,500	3,900	2,900	5,000	2,000	1,000	1,423	1,967	2,226	2,884	1,823	2,250	1,714	2,213	1,553	638	718	437	966	317	282	273	220	523	772	396	442	483	336	250	125	184
Interest expense
25,800	21,700	17,900	18,300	19,900	24,500	24,600	25,000	24,100	25,100	25,000	24,800	23,500	24,900	24,000	24,000	24,000	23,207	19,971	3,971	651	567	655	715	1,063	807	1,078	1,056	1,171	1,181	1,855	2,079	2,287	183	204	203	198	174	162	158	210	80	109
Other income and (expense)
-900	33,000	400	100	2,400	2,000	2,200	-1,200	2,500	200	-1,400	-100	1,600	-1,200	-1,000	-3,000	0	-1,055	2,795	-2,045	1,005	-11	-2,045	-1,202	1,258	-841	-547	-90	503	-391	-416	-186	-215	-1,329	-841	-506	395	-1,050	-427	-420	-537	-250	264
Debt exchange expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,395
Income before income taxes
663,600	602,000	535,500	499,500	541,800	-32,900	342,100	-418,600	351,600	89,300	58,200	206,300	194,000	104,200	159,000	170,000	143,000	74,504	139,359	177,292	106,945	205,234	236,209	218,646	211,911	137,977	134,288	137,263	116,741	107,270	140,765	81,722	67,809	74,078	65,677	49,087	40,826	44,248	42,607	32,083	30,073	27,682	17,894
Income tax expense (benefit)
106,000	-287,000	67,900	39,700	-46,100	12,100	11,200	38,800	102,500	59,300	-19,800	41,100	23,900	10,800	65,000	50,000	51,000	7,885	323,116	7,077	15,622	51,814	58,478	52,151	52,557	156,969	40,503	41,378	34,524	26,298	48,586	45,464	22,396	25,908	107	14,342	13,996	17,798	14,734	10,310	9,139	951	1,092
Net income
557,600	889,000	467,600	459,800	587,900	-45,000	330,900	-457,400	249,100	30,000	78,000	165,200	170,100	93,400	94,000	120,000	92,000	66,619	-183,757	170,215	91,323	153,420	177,731	166,495	159,354	-18,992	93,785	95,885	82,217	80,972	92,179	36,258	45,413	48,170	65,570	34,745	26,830	26,450	27,873	21,773	20,934	26,731	16,802
Earnings per common share
Basic
2.52	4.00	2.09	2.05	2.63	-0.20	1.48	-2.05	1.12	0.13	0.35	0.74	0.76	0.41	0.42	0.54	0.41	0.19	-0.81	0.84	0.46	0.77	0.90	0.84	0.81	-0.10	0.48	0.49	0.42	0.43	0.48	0.19	0.24	0.26	0.36	0.19	0.15	0.02	0.16	0.12	0.24	0.31	0.20
Diluted
2.50	3.97	2.08	2.04	2.61	-0.18	1.47	-2.05	1.11	0.14	0.35	0.73	0.75	0.40	0.42	0.53	0.41	0.20	-0.81	0.83	0.45	0.76	0.88	0.83	0.79	-0.09	0.47	0.48	0.41	0.41	0.46	0.18	0.23	0.25	0.34	0.18	0.14	0.02	0.15	0.12	0.23	0.29	0.19
Shares used in computing earnings per common share
Basic
221,600	221,500	223,300	224,200	223,800	223,200	222,900	222,600	222,100	223,300	223,300	224,400	224,600	224,200	224,000	224,000	225,000	225,777	226,228	202,234	199,361	198,271	198,052	197,880	197,797	196,448	195,662	195,247	194,771	194,234	193,353	188,575	185,682	184,488	183,706	182,962	181,724	268,678	178,980	178,004	88,506	87,447	85,128
Diluted
222,600	223,600	224,500	225,600	225,500	227,100	224,600	222,600	223,700	224,900	225,000	225,500	226,200	226,200	226,000	226,000	227,000	230,792	226,228	204,546	202,034	203,359	201,313	201,524	201,804	200,781	199,711	199,299	199,057	201,251	201,142	197,051	194,560	193,510	192,161	191,187	190,366	281,014	186,042	185,150	92,090	90,946	90,159
Comprehensive income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48,790	-	82,093	29,393	19,695	-	-	-	-	-	-
Net Product Sales
Total revenues
1,444,600	1,384,200	1,263,100	1,202,500	1,140,200	1,128,500	1,026,500	1,044,700	930,400	909,400	858,800	912,200	869,100	830,700	798,000	753,000	700,000	700,393	665,791	635,983	600,333	599,743	555,146	512,495	566,616	441,909	400,405	370,091	338,941	320,526	294,136	274,719	244,733	227,559	204,047	185,699	166,126	155,976	141,569	125,834	117,578	102,628	92,256
Other Revenue
Total revenues
200	100	0	800	200	300	0	300	500	300	300	500	500	400	1,000	0	1,000	427	846	227	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-